• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Lite Strategy to Attend Panel at Litecoin Foundation Summit in Amsterdam

    6/19/26 8:30:00 AM ET
    $LITS
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $LITS alert in real time by email

    SAN DIEGO, June 19, 2026 (GLOBE NEWSWIRE) -- Lite Strategy, Inc. (NASDAQ:LITS) ("Lite Strategy" or the "Company"), the first U.S. public company to adopt Litecoin (LTC) as its primary treasury reserve asset, today announced its participation in a featured panel at the Litecoin Foundation Summit, taking place June 22-23, 2026 at the Tobacco Theatre in Amsterdam, Netherlands.

    The Litecoin Foundation Summit is the flagship annual gathering of the Litecoin ecosystem, held this year in collaboration with Dutch Blockchain Week. The two-day event brings together builders, institutional voices, and community members for discussions spanning payments, privacy, and sound money.

    The panel will feature Lite Strategy Board Members Charlie Lee, creator of Litecoin and Director at the Litecoin Foundation, and Joshua Riezman, Chief Strategy Officer and Head of U.S. Legal at GSR. The panel will be moderated by Randi Hipper, Digital Asset Educator or Host of The Daily Zest Podcast. This marks Lite Strategy's first appearance at the Summit and the first time a NASDAQ-listed digital asset treasury company has taken the stage at the annual event.

    Jay File, CEO and CFO of Lite Strategy, said, "The Litecoin community is one of the most dedicated and passionate in the entire digital asset space. Getting in front of them directly, hearing what they care about, and showing them what we're building at Lite Strategy is something we've been looking forward to. Our focus remains on building lasting value through disciplined capital allocation, generating yield on our LTC holdings, and advancing the institutional credibility of Litecoin as a reserve asset."

    Charlie Lee, Lite Strategy Board Member and creator of Litecoin, said "Each year the Litecoin Summit brings together the builders, allocators, and institutions that are shaping where this asset class goes next and reflect on how far we've come. This year, for the first time, we have a NASDAQ digital asset treasury company on the stage, and that shows the institutional direction where Litecoin is being adopted."

    Panel Details:

    • Event: Litecoin Foundation Summit 2026
    • Panel Title: Litecoin's institutional opportunity
    • Location: Tobacco Theatre, Amsterdam
    • Date & Time: June 22, 2026, 14:00 CEST
    • Panelists: Charlie Lee (Creator of Litecoin, LITS Board Member), Joshua Riezman (CSO and Head of U.S. Legal, GSR; LITS Board Member)
    • Moderator: Randi Hipper

    Litecoin enters the Summit with 14 years of uninterrupted uptime and over 390 million transactions processed, a track record no newer digital asset can match. That foundation is now drawing serious institutional attention. The SEC's March 2026 guidance classifying LTC as a digital commodity, the October 2025 launch of the Canary spot Litecoin ETF on Nasdaq, and the formation of the first NASDAQ-listed active Litecoin treasury company have collectively established a credible on-ramp for allocators and treasury managers looking for proven, liquid digital asset exposure.

    About Lite Strategy, Inc.

    Lite Strategy, Inc. (NASDAQ:LITS) is the first U.S. publicly traded company to adopt Litecoin as its primary treasury reserve asset. Lite Strategy employs an active treasury management strategy including a covered call options program to generate yield on its LTC holdings and create lasting shareholder value. Lite Strategy offers investors regulated, transparent, and actively managed exposure to Litecoin that no ETF or passive vehicle can replicate. Lite Strategy also retains a portfolio of pharmaceutical assets, providing unique strategic optionality independent of digital asset treasury. For more information, visit www.litestrategy.com.

    Forward-Looking Statements

    Certain information contained in this press release that are not historical in nature are "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 including, without limitation, statements regarding our future actions, prospective products and activities, future performance or results. You should be aware that our actual results could differ materially from those contained in the forward-looking statements, which are based on management's current expectations and are subject to a number of risks and uncertainties, including, but not limited to, risk relating to being able to utilize our repurchase program to repurchase our shares in the market on attractive terms or at all, maintaining our current listing on Nasdaq, our ability to retain and attract senior management and other key employees, fluctuations in the market price of LTC and any associated impairment charges that we may incur as a result of a decrease in the market price of LTC below the value at which LTC is carried on our balance sheet, changes in the accounting treatment relating to our LTC holdings, our ability to achieve profitable operations, government regulation of cryptocurrencies and online betting, changes in securities laws or regulations, customer acceptance of new products and services including our LTC treasury strategy, the demand for our products and our customers' economic condition, the impact of competitive products and pricing, our proprietary rights, general economic conditions and other risk factors detailed in our annual report and other filings with the Securities and Exchange Commission. We do not intend to update any of these factors or to publicly announce the results of any revisions to these forward-looking statements.

    Contacts:

    Investor Relations: investor@litestrategy.com

    Public Relations: media@litestrategy.com



    Primary Logo

    Get the next $LITS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $LITS

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $LITS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Flynn James P bought $97,699 worth of shares (70,000 units at $1.40), increasing direct ownership by 233% to 100,000 units (SEC Form 4)

    4 - Lite Strategy, Inc. (0001262104) (Issuer)

    12/22/25 4:00:03 PM ET
    $LITS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Flynn James P bought $22,777 worth of shares (12,100 units at $1.88), increasing direct ownership by 68% to 30,000 units (SEC Form 4)

    4 - Lite Strategy, Inc. (0001262104) (Issuer)

    11/20/25 4:00:03 PM ET
    $LITS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $LITS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Lite Strategy to Attend Panel at Litecoin Foundation Summit in Amsterdam

    SAN DIEGO, June 19, 2026 (GLOBE NEWSWIRE) -- Lite Strategy, Inc. (NASDAQ:LITS) ("Lite Strategy" or the "Company"), the first U.S. public company to adopt Litecoin (LTC) as its primary treasury reserve asset, today announced its participation in a featured panel at the Litecoin Foundation Summit, taking place June 22-23, 2026 at the Tobacco Theatre in Amsterdam, Netherlands. The Litecoin Foundation Summit is the flagship annual gathering of the Litecoin ecosystem, held this year in collaboration with Dutch Blockchain Week. The two-day event brings together builders, institutional voices, and community members for discussions spanning payments, privacy, and sound money. The panel will feat

    6/19/26 8:30:00 AM ET
    $LITS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Lite Strategy Leads Strategic Investment in LitVM

    SAN DIEGO, June 18, 2026 (GLOBE NEWSWIRE) -- Lite Strategy, Inc. (NASDAQ:LITS) ("Lite Strategy" or the "Company"), the first U.S. public company to adopt Litecoin (LTC) as its primary treasury reserve asset, today announced the closing of a $1.0 million lead strategic investment in ZK Innovations Inc., the developer of LitVM, the first zero-knowledge (ZK) Layer 2 platform built on Litecoin. The investment reflects Lite Strategy's belief that increasing Litecoin's utility and functionality can strengthen the network and increase long-term shareholder value. In addition to the investment, Lite Strategy received governance participation rights and the opportunity to acquire a portion of LitV

    6/18/26 8:30:00 AM ET
    $LITS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Lite Strategy Reports Fiscal 2026 Third Quarter Results

    SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- Lite Strategy, Inc. (NASDAQ:LITS) ("Lite Strategy" or the "Company"), the first U.S. public company to adopt Litecoin (LTC) as its primary treasury reserve asset, today announced financial results for the fiscal 2026 third quarter ended March 31, 2026. Business and Financial Highlights: Active Treasury Management: Successfully continued the Company's covered call option program, generating $0.7 million in net proceeds since October 2025 and further demonstrating Lite Strategy's ability to transform its LTC holdings into a yield-generating reserve asset and differentiate itself from passive investment vehicles.Share Repurchase Program: Deployed

    5/13/26 8:30:00 AM ET
    $LITS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $LITS
    SEC Filings

    View All

    Lite Strategy Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Lite Strategy, Inc. (0001262104) (Filer)

    5/13/26 8:35:15 AM ET
    $LITS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 10-Q filed by Lite Strategy Inc.

    10-Q - Lite Strategy, Inc. (0001262104) (Filer)

    5/13/26 8:30:40 AM ET
    $LITS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Lite Strategy Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Lite Strategy, Inc. (0001262104) (Filer)

    2/17/26 8:50:24 AM ET
    $LITS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $LITS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by CEO, CFO and Secretary File Justin J.

    4 - Lite Strategy, Inc. (0001262104) (Issuer)

    2/12/26 5:44:48 PM ET
    $LITS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Schornstein Alexander sold $946,137 worth of shares (690,611 units at $1.37), decreasing direct ownership by 16% to 3,674,862 units (SEC Form 4)

    4 - Lite Strategy, Inc. (0001262104) (Issuer)

    12/22/25 4:15:14 PM ET
    $LITS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Flynn James P bought $97,699 worth of shares (70,000 units at $1.40), increasing direct ownership by 233% to 100,000 units (SEC Form 4)

    4 - Lite Strategy, Inc. (0001262104) (Issuer)

    12/22/25 4:00:03 PM ET
    $LITS
    Biotechnology: Pharmaceutical Preparations
    Health Care